ES2082979T3 - Derivados de bis-dioxopiperazina hidrosolubles con propiedades antitumorales. - Google Patents

Derivados de bis-dioxopiperazina hidrosolubles con propiedades antitumorales.

Info

Publication number
ES2082979T3
ES2082979T3 ES91911753T ES91911753T ES2082979T3 ES 2082979 T3 ES2082979 T3 ES 2082979T3 ES 91911753 T ES91911753 T ES 91911753T ES 91911753 T ES91911753 T ES 91911753T ES 2082979 T3 ES2082979 T3 ES 2082979T3
Authority
ES
Spain
Prior art keywords
elevado
hydro
tumor properties
soluble bis
hidrogeno
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91911753T
Other languages
English (en)
Inventor
Muneaki Takase
Toshiharu Narita
Toshihiko Komatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zenyaku Kogyo KK
Original Assignee
Zenyaku Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zenyaku Kogyo KK filed Critical Zenyaku Kogyo KK
Application granted granted Critical
Publication of ES2082979T3 publication Critical patent/ES2082979T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

UNA SAL DE ADICION ACIDA DE UN DENVADO DE BIS-DIOXOPIPERAZINA REPRESENTADO POR LA FORMULA GENERAL (I), EN LA QUE R ELEVADO 1 REPRESENTA ALQUILO C SUB 1 A C SUB 6; R ELEVADO 2 REPRESENTA HIDROGENO O (A); R ELEVADO 3 REPRESENTA HIDROGENO, ALQUILO C ELEVADO 1 A C ELEVADO 6 O PRESENTA CARBOXILO, BENCILOXICARBONILO, MERCAPTO, AMINO, BENCILOXICARBONILAMINO O (B), DONDE X REPRESENTA HIDROGENO, TRIFLUOROMETILO, HIDROXI, ACETOXI O BENCILOXI, Y N REPRESENTA UN NUMERO ENTERO DE 1 A 4; Y R ELEVADO 4 REPRESENTA HIDROGENO O COMO ALTERNATIVA R ELEVADO 4 Y R ELEVADO 2 SE COMBINAN JUNTOS PARA REPRESENTAR UN GRUPO CICLICO DE 5 MIEMBROS QUE, OPCIONALMENTE, CONTIENE AZUFRE.
ES91911753T 1990-07-04 1991-07-03 Derivados de bis-dioxopiperazina hidrosolubles con propiedades antitumorales. Expired - Lifetime ES2082979T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17667290 1990-07-04

Publications (1)

Publication Number Publication Date
ES2082979T3 true ES2082979T3 (es) 1996-04-01

Family

ID=16017706

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91911753T Expired - Lifetime ES2082979T3 (es) 1990-07-04 1991-07-03 Derivados de bis-dioxopiperazina hidrosolubles con propiedades antitumorales.

Country Status (10)

Country Link
US (1) US5393889A (es)
EP (1) EP0491053B1 (es)
JP (1) JP3050598B2 (es)
AU (1) AU642519B2 (es)
CA (1) CA2065291A1 (es)
DE (1) DE69117025T2 (es)
DK (1) DK0491053T3 (es)
ES (1) ES2082979T3 (es)
NO (1) NO920836D0 (es)
WO (1) WO1992000971A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ309069B6 (cs) 2020-01-16 2022-01-12 Univerzita Karlova V Praze Použití derivátů sloučeniny ICRF-193 a farmaceutický přípravek k prevenci chronické kumulativní kardiotoxicity způsobené terapií antracyklinovými protinádorovými léčivy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737497A (en) * 1983-04-12 1988-04-12 Zenyaki Kogyo Kabushiki Kaisha Bis-dioxopiperazine derivatives, antitumor agents comprising them and compositions containing them
JPS6097963A (ja) * 1983-10-31 1985-05-31 Zenyaku Kogyo Kk ビス−ジオキソピペラジン誘導体，その製造方法及びそれからなる抗腫瘍剤
JPS61152660A (ja) * 1984-12-26 1986-07-11 Zenyaku Kogyo Kk ビス−ジオキソピペラジン誘導体
JPH0676392B2 (ja) * 1985-06-26 1994-09-28 全薬工業株式会社 ビス−ジオキソピペラジン誘導体及びそれからなる抗腫瘍剤
JPS62135472A (ja) * 1985-12-10 1987-06-18 Yakult Honsha Co Ltd 新規な１，２−ビス−３，５−ジオキソピペラジニルエタン誘導体
JPH0674251B2 (ja) * 1986-02-07 1994-09-21 全薬工業株式▲会▼社 ビス−ジオキソピペラジン誘導体
JP2619042B2 (ja) * 1988-01-27 1997-06-11 三共株式会社 ビスジオキソピペラジン誘導体
US4963679A (en) * 1988-02-17 1990-10-16 Erbamont, Inc. Process for preparing bis (3,5-dioxopiperazinyl) alkanes or alkenes
GB8916072D0 (en) * 1989-07-13 1989-08-31 Creighton Andrew M Pharmaceutical compositions

Also Published As

Publication number Publication date
DE69117025T2 (de) 1996-06-20
DE69117025D1 (de) 1996-03-21
EP0491053B1 (en) 1996-02-07
JP3050598B2 (ja) 2000-06-12
WO1992000971A1 (fr) 1992-01-23
NO920836L (no) 1992-03-03
AU642519B2 (en) 1993-10-21
DK0491053T3 (da) 1996-03-11
NO920836D0 (no) 1992-03-03
CA2065291A1 (en) 1992-01-05
AU8189091A (en) 1992-02-04
EP0491053A1 (en) 1992-06-24
US5393889A (en) 1995-02-28
EP0491053A4 (en) 1992-12-02

Similar Documents

Publication Publication Date Title
KR850007597A (ko) 항균제의 제법
CO4290349A1 (es) Procedimiento para la preparacion de propanamina asimetrica
UA39099C2 (uk) Циклічні азотовмісні похідні, суміш їх ізомерів або окремі ізомери, або їх солі
PT83961B (pt) Processo para a preparacao de derivados da pirazolina e de composicoes insecticidas e acaricidas que os contem
ES2032456T3 (es) Procedimiento para preparar derivados de 1,2,5,6-tetrahidropiridin-3-carboxaldehido-oxima.
KR960702830A (ko) 방사선 보호제로서의 N-알킬티오 폴리아민 유도체(N-Alkylthio polyaine derivatives as radioprotective agents)
ES2088574T3 (es) Derivado de anilida.
FI862868A0 (fi) Nya aminofenoler och deras anvaendning i oxiderbara haorfaergmedel.
ES2056153T3 (es) Expectorante que comprende un derivado hidroxialquilcisteina.
ES2092868T3 (es) Utilizacion de derivados de la 4-tiorresorcina en unas composiciones cosmeticas o dermofarmaceuticas de accion despigmentante.
ES2039195T3 (es) Derivado de la pirazolsulfonamida, procedimiento para su fabricacion y herbicida que lo contiene.
FI875353A0 (fi) Cytostatiskt verkande antracyklinderivat.
ES2117132T3 (es) Sales de desferrioxamina-b y su uso como queladores de hierro eficaces por via oral.
AR009120A1 (es) Una composicion de grasa de urea y mecanismos que contienen tal composicion
ES2019554A6 (es) Procedimiento para preparar n,n -ditrimetoxibenzoilpiperazinas sustituidas en posicion 2"
ES2082979T3 (es) Derivados de bis-dioxopiperazina hidrosolubles con propiedades antitumorales.
ES2189736T3 (es) Derivados de la benzamida y medicamentos que los contienen.
ES8505994A1 (es) Un metodo para preparar 2(1h)-piridinonas
MX9304388A (es) Polopeptido sintetico y proceso para su fabricacion.
ES444493A1 (es) Procedimiento para la preparacion del acido, 4,4'-bis-(2" , 4"-bis-diisopropilamino)-5-triacin-6"-il-amino)-estilben-2, 2'-disulfonico y sus sales.
ES474921A1 (es) Un procedimiento para la preparacion de 2,4-diamino-5-bencil-pirimidinas
ES2073951T3 (es) Derivados de 2-amino-n-(((4-(aminocarbonil)pirimidin-2-il)amino)alquil)pirimidina-4-carboxamida, su preparacion y su aplicacion en terapeutica.
ES8203368A1 (es) Procedimiento de producir amidas ciclicas
KR900016226A (ko) 세포디짐 나트륨의 제조방법
ES2085833B1 (es) Derivados de carboximetilidencicloheptimidazol y metodo para prepararlos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 491053

Country of ref document: ES